Brain-derived neurotrophic factor prevents the endothelial barrier dysfunction induced by interleukin-1β and tumor necrosis factor-α

Journal of Periodontal Research

Volumn 50, Issue 4, 2015, Pages 444-451

  Matsuda, S ^a   Fujita, T ^a   Kajiya, M ^a   Kashiwai, K ^a   Takeda, K ^a   Shiba, H ^a   Kurihara, H ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Brain derived neurotrophic factor; Endothelial cell permeability; Inflammatory cytokine; Periodontal tissue regeneration

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CADHERIN; CARBAZOLE DERIVATIVE; DEXTRAN; ENZYME INHIBITOR; FLUORESCEIN ISOTHIOCYANATE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; FLUORESCENT DYE; INDOLE ALKALOID; INTERLEUKIN 1BETA; LEUKOCYTE ANTIGEN; STAUROSPORINE AGLYCONE; TUMOR NECROSIS FACTOR; VASCULAR ENDOTHELIAL CADHERIN;

ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL LINE; CELL MEMBRANE PERMEABILITY; DRUG EFFECTS; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOBLOTTING; VASCULAR ENDOTHELIUM;

ANTIGENS, CD; BRAIN-DERIVED NEUROTROPHIC FACTOR; CADHERINS; CARBAZOLES; CELL LINE; CELL MEMBRANE PERMEABILITY; DEXTRANS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; IMMUNOBLOTTING; INDOLE ALKALOIDS; INTERLEUKIN-1BETA; MICROSCOPY, FLUORESCENCE; RECEPTOR, TRKB; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84935056471     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12226     Document Type: Article

References (63)

1. Barbacid M. The Trk family of neurotrophin receptors. J Neurobiol 1994;25:1386-1403.
2. Ebendal T. Function and evolution in the NGF family and its receptors. J Neurosci Res 1992;32:461-470.
3. Johnson JE, Barde YA, Schwab M, Thoenen H. Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci 1986;6:3031-3038.
4. Radeke MJ, Misko TP, Hsu C, Herzenberg LA, Shooter EM. Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 1987;325:593-597.
5. Memberg SP, Hall AK. Proliferation, differentiation, and survival of rat sensory neuron precursors in vitro require specific trophic factors. Mol Cell Neurosci 1995;6:323-335.
6. Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000;14:2919-2937.
7. Hempstead BL. The many faces of p75NTR. Curr Opin Neurobiol 2002;12:260-267.
8. Furukawa Y, Furukawa S, Satoyoshi E, Hayashi K. Nerve growth factor secreted by mouse heart cells in culture. J Biol Chem 1984;259:1259-1264.
9. MacGrogan D, Saint-Andre JP, Dicou E. Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines. J Neurochem 1992;59:1381-1391.
10. Nosrat CA, Fried K, Lindskog S, Olson L. Cellular expression of neurotrophin mRNAs during tooth development. Cell Tissue Res 1997;290:569-580.
11. Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA 1989;86:10059-10063.
12. Yamashiro T, Fukunaga T, Yamashita K, Kobashi N, Takano-Yamamoto T. Gene and protein expression of brain-derived neurotrophic factor and TrkB in bone and cartilage. Bone 2001;28:404-409.
13. Kerschensteiner M, Gallmeier E, Behrens L et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 1999;189:865-870.
14. Kurihara H, Shinohara H, Yoshino H, Takeda K, Shiba H. Neurotrophins in cultured cells from periodontal tissues. J Periodontol 2003;74:76-84.
15. Nakahashi T, Fujimura H, Altar CA et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 2000;470:113-117.
16. Nakanishi T, Takahashi K, Aoki C, Nishikawa K, Hattori T, Taniguchi S. Expression of nerve growth factor family neurotrophins in a mouse osteoblastic cell line. Biochem Biophys Res Commun 1994;198:891-897.
17. Asaumi K, Nakanishi T, Asahara H, Inoue H, Takigawa M. Expression of neurotrophins and their receptors (TRK) during fracture healing. Bone 2000;26:625-633.
18. Donovan MJ, Lin MI, Wiegn P et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 2000;127:4531-4540.
19. Kermani P, Hempstead B. Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc Med 2007;17:140-143.
20. Kajiya M, Shiba H, Fujita T et al. Brain-derived neurotrophic factor stimulates bone/cementum-related protein gene expression in cementoblasts. J Biol Chem 2008;283:16259-16267.
21. Kajiya M, Shiba H, Fujita T et al. Brain-derived neurotrophic factor protects cementoblasts from serum starvation-induced cell death. J Cell Physiol 2009;221:696-706.
22. Takeda K, Shiba H, Mizuno N et al. Brain-derived neurotrophic factor enhances periodontal tissue regeneration. Tissue Eng 2005;11:1618-1629.
23. Takeda K, Sakai N, Shiba H et al. Characteristics of high-molecular-weight hyaluronic acid as a brain-derived neurotrophic factor scaffold in periodontal tissue regeneration. Tissue Eng Part A 2011;17:955-967.
24. Matsuda S, Fujita T, Kajiya M et al. Brain-derived neurotrophic factor induces migration of endothelial cells through a TrkB-ERK-integrin alphaVbeta3-FAK cascade. J Cell Physiol 2012;227:2123-2129.
25. Kato M, Suzuki H, Murakami M, Akama M, Matsukawa S, Hashimoto Y. Elevated plasma levels of interleukin-6, interleukin-8, and granulocyte colony-stimulating factor during and after major abdominal surgery. J Clin Anesth 1997;9:293-298.
26. Takahashi J, Ebara S, Kamimura M et al. Pro-inflammatory and anti-inflammatory cytokine increases after spinal instrumentation surgery. J Spinal Disord Tech 2002;15:294-300.
27. Aveleira CA, Lin CM, Abcouwer SF, Ambrosio AF, Antonetti DA. TNF-alpha signals through PKCzeta/NF-kappaB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes 2010;59:2872-2882.
28. Norman MU, Lister KJ, Yang YH, Issekutz A, Hickey MJ. TNF regulates leukocyte-endothelial cell interactions and microvascular dysfunction during immune complex-mediated inflammation. Br J Pharmacol 2005;144:265-274.
29. Petrache I, Birukova A, Ramirez SI, Garcia JG, Verin AD. The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am J Respir Cell Mol Biol 2003;28:574-581.
30. Ma TY, Iwamoto GK, Hoa NT et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 2004;286:G367-G376.
31. Carmeliet P, Lampugnani MG, Moons L et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 1999;98:147-157.
32. Feng D, Nagy JA, Dvorak AM, Dvorak HF. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. Microvasc Res 2000;59:24-37.
33. Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012;2012:918267.
34. Bitto A, Minutoli L, Galeano MR et al. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression. Clin Sci 2008;114:707-718.
35. Vestweber D, Broermann A, Schulte D. Control of endothelial barrier function by regulating vascular endothelial-cadherin. Curr Opin Hematol 2010;17:230-236.
36. Lampugnani MG, Resnati M, Raiteri M et al. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 1992;118:1511-1522.
37. Friedl J, Puhlmann M, Bartlett DL et al. Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. Blood 2002;100:1334-1339.
38. Puhlmann M, Weinreich DM, Farma JM, Carroll NM, Turner EM, Alexander HR Jr. Interleukin-1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity. J Transl Med 2005;3:37.
39. Friedl J, Turner E, Alexander HR Jr. Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation. Int J Oncol 2003;23:611-616.
40. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 2006;8:1223-1234.
41. Zhang G, Dong H, Xu Z, Zhao D, Zhang C. Microbial diversity in ultra-high-pressure rocks and fluids from the Chinese Continental Scientific Drilling Project in China. Appl Environ Microbiol 2005;71:3213-3227.
42. Fujita T, Yumoto H, Shiba H et al. Irsogladine maleate regulates epithelial barrier function in tumor necrosis factor-alpha-stimulated human gingival epithelial cells. J Periodontal Res 2012;47:55-61.
43. Kajiya M, Takeshita K, Kittaka M et al. BDNF mimetic compound LM22A-4 regulates cementoblast differentiation via the TrkB-ERK/Akt signaling cascade. Int Immunopharmacol 2014;19:245-252.
44. Cooper PR, Takahashi Y, Graham LW, Simon S, Imazato S, Smith AJ. Inflammation-regeneration interplay in the dentine-pulp complex. J Dent 2010;38:687-697.
45. Goertz O, Ring A, Buschhaus B et al. Influence of anti-inflammatory and vasoactive drugs on microcirculation and angiogenesis after burn in mice. Burns 2011;37:656-664.
46. Lacey DC, Simmons PJ, Graves SE, Hamilton JA. Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis Cartilage 2009;17:735-742.
47. Rasband WS, ImageJ, U. S. National Institutes of Health, Bethesda, MD. http://imagej.nih.gov/ij/, 1997-2014.
48. Wu G, Liu Y, Iizuka T, Hunziker EB. The effect of a slow mode of BMP-2 delivery on the inflammatory response provoked by bone-defect-filling polymeric scaffolds. Biomaterials 2010;31:7485-7493.
49. Ratanavaraporn J, Furuya H, Tabata Y. Local suppression of pro-inflammatory cytokines and the effects in BMP-2-induced bone regeneration. Biomaterials 2012;33:304-316.
50. Nwariaku FE, Liu Z, Zhu X et al. NADPH oxidase mediates vascular endothelial cadherin phosphorylation and endothelial dysfunction. Blood 2004;104:3214-3220.
51. Shivanna M, Srinivas SP. Elevated cAMP opposes (TNF-alpha)-induced loss in the barrier integrity of corneal endothelium. Molecular Vision 2010;16:1781-1790.
52. Morris RE. Prevention and treatment of allograft rejection in vivo by rapamycin: molecular and cellular mechanisms of action. Ann N Y Acad Sci 1993;685:68-72.
53. Morris RE. Immunopharmacology of new xenobiotic immunosuppressive molecules. Semin Nephrol 1992;12:304-314.
54. Fainaru O, Adini I, Benny O et al. Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J 2008;22:3728-3735.
55. Argaw AT, Zhang Y, Snyder BJ et al. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol 2006;177:5574-5584.
56. Yuan X, Li B, Li H, Xiu R. Melatonin inhibits IL-1beta-induced monolayer permeability of human umbilical vein endothelial cells via Rac activation. J Pineal Res 2011;51:220-225.
57. Li YZ, Liu XH, Rong F, Hu S, Sheng ZY. Carbachol inhibits TNF-alpha-induced endothelial barrier dysfunction through alpha 7 nicotinic receptors. Acta Pharmacol Sin 2010;31:1389-1394.
58. Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol 2007;127:2525-2532.
59. Barker PA, Murphy RA. The nerve growth factor receptor: a multicomponent system that mediates the actions of the neurotrophin family of proteins. Mol Cell Biochem 1992;110:1-15.
60. Yan XZ, Ge SH, Sun QF, Guo HM, Yang PS. A pilot study evaluating the effect of recombinant human bone morphogenetic protein-2 and recombinant human beta-nerve growth factor on the healing of Class III furcation defects in dogs. J Periodontol 2010;81:1289-1298.
61. Mizuno N, Shiba H, Inui T et al. Effect of neurotrophin-4/5 on bone/cementum-related protein expressions and DNA synthesis in cultures of human periodontal ligament cells. J Periodontol 2008;79:2182-2189.
62. Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 2001;11:272-280.
63. Lee K, Silva EA, Mooney DJ. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 2011;8:153-170.